[Quantitative serum protein determinations in paraproteinemic hemoblastoses].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis*; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D010954:Plasmacytoma / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis; D005719:gamma-Globulins / Q000032:analysis
D000970:Antineoplastic Agents; D001798:Blood Proteins; D012709:Serum Albumin; D012712:Serum Globulins; D005719:gamma-Globulins
Quantiative Serumproteinbestimmungen bei paraproteinämischen Hämoblastosen.